1. Home
  2. CVM vs KOSS Comparison

CVM vs KOSS Comparison

Compare CVM & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVM
  • KOSS
  • Stock Information
  • Founded
  • CVM 1983
  • KOSS 1953
  • Country
  • CVM United States
  • KOSS United States
  • Employees
  • CVM N/A
  • KOSS N/A
  • Industry
  • CVM Biotechnology: Biological Products (No Diagnostic Substances)
  • KOSS Consumer Electronics/Appliances
  • Sector
  • CVM Health Care
  • KOSS Consumer Staples
  • Exchange
  • CVM Nasdaq
  • KOSS Nasdaq
  • Market Cap
  • CVM 71.2M
  • KOSS 57.5M
  • IPO Year
  • CVM 1987
  • KOSS N/A
  • Fundamental
  • Price
  • CVM $10.03
  • KOSS $5.69
  • Analyst Decision
  • CVM
  • KOSS
  • Analyst Count
  • CVM 0
  • KOSS 0
  • Target Price
  • CVM N/A
  • KOSS N/A
  • AVG Volume (30 Days)
  • CVM 303.9K
  • KOSS 77.2K
  • Earning Date
  • CVM 08-14-2025
  • KOSS 10-30-2025
  • Dividend Yield
  • CVM N/A
  • KOSS N/A
  • EPS Growth
  • CVM N/A
  • KOSS N/A
  • EPS
  • CVM N/A
  • KOSS N/A
  • Revenue
  • CVM N/A
  • KOSS $12,624,170.00
  • Revenue This Year
  • CVM N/A
  • KOSS N/A
  • Revenue Next Year
  • CVM N/A
  • KOSS N/A
  • P/E Ratio
  • CVM N/A
  • KOSS N/A
  • Revenue Growth
  • CVM N/A
  • KOSS 2.93
  • 52 Week Low
  • CVM $1.98
  • KOSS $4.00
  • 52 Week High
  • CVM $39.30
  • KOSS $8.59
  • Technical
  • Relative Strength Index (RSI)
  • CVM 52.57
  • KOSS 42.60
  • Support Level
  • CVM $9.58
  • KOSS $5.95
  • Resistance Level
  • CVM $12.68
  • KOSS $6.29
  • Average True Range (ATR)
  • CVM 1.30
  • KOSS 0.29
  • MACD
  • CVM -0.28
  • KOSS -0.09
  • Stochastic Oscillator
  • CVM 28.57
  • KOSS 7.20

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.

Share on Social Networks: